Figure 6
Figure 6. Cofactor activity of mutants lacking Lys 2092 and/or Phe 2093 as a function of Ptd-L-Ser content in phospholipid vesicles. (A) Activity of fVIIIYFP (■) was compared with fVIIIYFP 2092 (▲) for vesicles with Ptd-L-Ser content ranging from 0% to 20%. (B) fVIIIYFP 2093 (▲) was compared with fVIIIYFP (■). (C) fVIIIYFP 2092/2093 (▲) was compared with fVIIIYFP (■). Results indicate that fVIIIYFP 2093 has intermediate impairment when Ptd-L-Ser content is less than 12%, whereas fVIIIYFP 2092 has activity approaching fVIIIYFP. The concentration of factor VIII was 1 U/mL, and vesicle composition was 0% to 20% Ptd-L-Ser, 20% PE, with the balance as PC. Assays were performed as for Figure 2. Each point represents the mean ± SEM for 3 experiments, each performed in duplicate. Data and curve for fVIIIYFP are displayed in panels A to C.

Cofactor activity of mutants lacking Lys 2092 and/or Phe 2093 as a function of Ptd-L-Ser content in phospholipid vesicles. (A) Activity of fVIIIYFP (■) was compared with fVIIIYFP 2092 (▲) for vesicles with Ptd-L-Ser content ranging from 0% to 20%. (B) fVIIIYFP 2093 (▲) was compared with fVIIIYFP (■). (C) fVIIIYFP 2092/2093 (▲) was compared with fVIIIYFP (■). Results indicate that fVIIIYFP 2093 has intermediate impairment when Ptd-L-Ser content is less than 12%, whereas fVIIIYFP 2092 has activity approaching fVIIIYFP. The concentration of factor VIII was 1 U/mL, and vesicle composition was 0% to 20% Ptd-L-Ser, 20% PE, with the balance as PC. Assays were performed as for Figure 2. Each point represents the mean ± SEM for 3 experiments, each performed in duplicate. Data and curve for fVIIIYFP are displayed in panels A to C.

Close Modal

or Create an Account

Close Modal
Close Modal